biblio
“Novel cilengitide-based cyclic RGD peptides as alpha nu beta(3) integrin inhibitors”, Bioorganic & Medicinal Chemistry Letters, vol. 30, no. 8, p. 127039, 2020.
, “Selective targeting of integrin alpha v beta 8 by a highly active cyclic peptide”, Journal of Medicinal Chemistry, vol. 62, no. 4, pp. 2024-2037, 2019.
, “Overcoming the lack of oral availability of cyclic hexapeptides: design of a selective and orally available ligand for the integrin alpha v beta 3”, Angewandte Chemie-International Edition, vol. 56, no. 51, pp. 16405-16409, 2017.
,